10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Beta-lactam antibiotics represent a crucial class of antimicrobials renowned for their efficacy in combating bacterial infections. This group includes penicillins, cephalosporins, carbapenems, and monobactams, all sharing a common beta-lactam ring structure. Mechanistically, these antibiotics target bacterial cell walls by inhibiting enzymes involved in peptidoglycan synthesis. Penicillins, the pioneering members of this class, exert their antimicrobial action by binding to penicillin-binding proteins (PBPs), disrupting cell wall formation, and inducing bacterial lysis. Cephalosporins, displaying a broader spectrum, act similarly by interfering with cell wall synthesis but offer resistance against certain beta-lactamases.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria